Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 367

1.

Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential.

Becker RC, Spencer FA, Li Y, Ball SP, Ma Y, Hurley T, Hebert J.

J Am Coll Cardiol. 1999 Oct;34(4):1020-7.

PMID:
10520784
[PubMed - indexed for MEDLINE]
Free Article
2.

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.

Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, Green C, Berrios E, Harrington RA, Ohman EM, et al.

Circulation. 1995 Apr 1;91(7):1929-35.

PMID:
7895349
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.

Salvioni A, Casilli F, Assanelli E, Grazi M, Marenzi G, Guazzi MD.

Thromb Haemost. 2001 Oct;86(4):991-4.

PMID:
11686357
[PubMed - indexed for MEDLINE]
4.

Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.

Hafner G, Rupprecht HJ, Luz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W.

Eur Heart J. 1996 Aug;17(8):1207-15.

PMID:
8869862
[PubMed - indexed for MEDLINE]
Free Article
5.

Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.

Bijsterveld NR, Moons AH, Meijers JC, Tijssen JG, Büller HR, Levi M, Peters RJ.

J Am Coll Cardiol. 2002 Mar 6;39(5):811-7.

PMID:
11869846
[PubMed - indexed for MEDLINE]
Free Article
6.

Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.

Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.

Eur Heart J. 2000 Sep;21(17):1473-81.

PMID:
10952840
[PubMed - indexed for MEDLINE]
Free Article
7.

Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.

Oldgren J, Linder R, Grip L, Siegbahn A, Wallentin L.

Eur Heart J. 1999 Nov;20(22):1657-66.

PMID:
10543929
[PubMed - indexed for MEDLINE]
Free Article
8.

The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.

Linder R, Oldgren J, Egberg N, Grip L, Larson G, Siegbahn A, Wallentin L.

Eur Heart J. 1999 Apr;20(7):506-18.

PMID:
10365287
[PubMed - indexed for MEDLINE]
Free Article
9.

Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.

Gold HK, Torres FW, Garabedian HD, Werner W, Jang IK, Khan A, Hagstrom JN, Yasuda T, Leinbach RC, Newell JB, et al.

J Am Coll Cardiol. 1993 Apr;21(5):1039-47.

PMID:
8459055
[PubMed - indexed for MEDLINE]
11.

Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.

Vila V, Martínez-Sales V, Réganon E, Peris E, Perez F, Ruano M, Aznar J.

Haematologica. 2001 Jul;86(7):729-34.

PMID:
11454528
[PubMed - indexed for MEDLINE]
Free Article
12.

Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial.

Giugliano RP, Wiviott SD, Stone PH, Simon DI, Schweiger MJ, Bouchard A, Leesar MA, Goulder MA, Deitcher SR, McCabe CH, Braunwald E; ANTHEM-TIMI-32 Investigators.

J Am Coll Cardiol. 2007 Jun 26;49(25):2398-407. Epub 2007 Jun 11.

PMID:
17599602
[PubMed - indexed for MEDLINE]
Free Article
13.

Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.

Galvani M, Abendschein DR, Ferrini D, Ottani F, Rusticali F, Eisenberg PR.

J Am Coll Cardiol. 1994 Nov 15;24(6):1445-52.

PMID:
7930274
[PubMed - indexed for MEDLINE]
Free Article
14.

Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions.

Watkins MW, Luetmer PA, Schneider DJ, Witmer WT, Vaitkus PT, Sobel BE.

Cathet Cardiovasc Diagn. 1998 Jul;44(3):257-64.

PMID:
9676792
[PubMed - indexed for MEDLINE]
15.

The impact on coagulation of an intravenous loading dose in addition to a subcutaneous regimen of low-molecular-weight heparin in the initial treatment of acute coronary syndromes.

Bijsterveld NR, Moons AH, Meijers JC, Levi M, Büller HR, Peters RJ.

J Am Coll Cardiol. 2003 Aug 6;42(3):424-7.

PMID:
12906966
[PubMed - indexed for MEDLINE]
Free Article
16.

Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes.

Merlini PA, Ardissino D, Bauer KA, Oltrona L, Pezzano A, Bottasso B, Rosenberg RD, Mannucci PM.

Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1325-30.

PMID:
9261263
[PubMed - indexed for MEDLINE]
Free Article
17.

Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty.

Smith AJ, Holt RE, Fitzpatrick JB, Palacios IF, Gold HK, Werner W, Bovill EG, Fuster V, Jang IK.

Am Heart J. 1996 Mar;131(3):434-9.

PMID:
8604621
[PubMed - indexed for MEDLINE]
18.

Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.

Grip L, Blombäck M, Egberg N, Olsson A, Svane B, Velander M.

Eur Heart J. 1997 Mar;18(3):443-9.

PMID:
9076381
[PubMed - indexed for MEDLINE]
Free Article
19.

Thrombin inhibition with inogatran for unstable angina pectoris: evidence for reactivated ischaemia after cessation of short-term treatment.

Andersen K, Dellborg M, Emanuelsson H, Grip L, Swedberg K.

Coron Artery Dis. 1996 Sep;7(9):673-81.

PMID:
8950498
[PubMed - indexed for MEDLINE]
20.

Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.

Wang XK, Zhang Y, Yang CM, Wang Y, Liu GY.

Clin Drug Investig. 2006;26(6):341-9.

PMID:
17163268
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk